Shefali Miglani
Optometrist · Monroe Twp, NJNPI 1306973987
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,500 of the $15,177 with a category attached, or 69.2%. Johnson & Johnson Vision Care, Inc. accounts for 96.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $10,775 and has fallen 98.5% since, to $163 in 2025. Among optometrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $237.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$15K
- Alcon$156
- Biotissue Holdings Inc.$107
- Dompe US, Inc.$55
- Carl Zeiss Meditec USA, Inc.$51
- Johnson & Johnson Surgical Vision, Inc.$37
- plus $146 from 7 others
What the payments were for
- Speaking & faculty fees$10,50069%
- Travel & lodging$3,12221%
- Food & beverage$1,51910%
- Gifts$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 41 | $14,625 |
| Alcon | 4 | $156 |
| Biotissue Holdings Inc. | 6 | $107 |
| Dompe US, Inc. | 1 | $55 |
| Carl Zeiss Meditec USA, Inc. | 1 | $51 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $37 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Kala Pharmaceuticals, Inc. | 2 | $31 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Coopervision Inc. | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,177 in reported general payments places this provider in the 95th percentile of 1,357 optometrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Travoprost | 14 | $2,997 |
| Loteprednol Etabonate | 17 | $2,397 |
| Brimonidine Tartrate | 13 | $1,151 |
| Latanoprost | 21 | $296 |
| Timolol Maleate | 16 | $190 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $172 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Monroe Twp
- Kerry GelbWoodbridge$264K
- Rodolfo RodriguezNorth Bergen$244K
- Steven SorkinFairfield$146K
- Paul VaccarellaRockaway$99K
- Ada NohCinnaminson$74K
- Melanne RosettaIselin$66K
- Frank BuccieroSpringfield$57K
- Victoria DzurinkoDeptford$47K
- Michael McAleeseHowell$33K
- Gary RochaParamus$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.